儿童泛发性脓疱性银屑病治疗进展

儿童泛发性脓疱性银屑病临床少见,约占儿童银屑病患儿的0.6％,其治疗难度较大.因儿童泛发性脓疱性银屑病具有自身的一些特征,其用药的疗效和安全性不完全同于成人,因此对药物的选择需要更加谨慎,甚至存在一定的限制,临床工作中应充分权衡疗效与安全性之比.一般认为,儿童系统治疗的疗程尽量不超过半年,以避免或减少药物长期使用的不良反应.概述维A酸、糖皮质激素、免疫抑制剂、抗生素、光疗及生物制剂治疗儿童泛发性脓疱性银屑病的进展.

Treatment of generalized pustular psoriasis in childhood

Childhood generalized pustular psoriasis is rare,and accounts for about 0.6％ of all the cases of psoriasis in children.Up to date,there has been no specific treatment for this disease in the world.Childhood generalized pustular psoriasis has its characteristics,and therapeutic effect and safety of drugs in children differ from those in adults,hence,the use of drugs in pediatric patients is limited and should be given more cautions,and the benefit and risk should be weighed sufficiently before the selection of drugs in clinical practice.It is generally believed that the course of systemic treatment in children should be no longer than half a year to avoid or reduce the long-term side effects of drugs.The authors review the advances in the treatment of childhood generalized pustular psoriasis with tretinoin,glucocorticoids,immunosuppressants,antibiotics,phototherapy and biological agents.